Free Trial

Evoke (LON:EVOK) Trading Down 20.6% - Should You Sell?

Evoke logo with Consumer Cyclical background
Remove Ads

Evoke plc (LON:EVOK - Get Free Report) shares dropped 20.6% during mid-day trading on Wednesday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 56.70 ($0.73). Approximately 7,646,775 shares were traded during trading, an increase of 273% from the average daily volume of 2,048,180 shares. The stock had previously closed at GBX 71.40 ($0.92).

Analysts Set New Price Targets

Several brokerages have issued reports on EVOK. Jefferies Financial Group restated a "buy" rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th. Berenberg Bank dropped their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a report on Wednesday, December 4th.

Read Our Latest Report on Evoke

Evoke Trading Down 1.1 %

The stock has a market cap of £224.78 million, a price-to-earnings ratio of -1.26 and a beta of 0.84. The stock's 50 day moving average is GBX 68.88 and its two-hundred day moving average is GBX 63.49.

Evoke (LON:EVOK - Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, sell-side analysts predict that Evoke plc will post 12.7648305 EPS for the current year.

Insider Transactions at Evoke

In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company's stock.

Evoke Company Profile

(Get Free Report)

Featured Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads